
CAS: 2092925-89-6
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Palazestrant REF: 54-BUP01207CAS: 2092925-89-6 | 97.55% | 1,955.00 €~4,220.00 € | Mon 21 Apr 25 |
![]() | Palazestrant REF: TM-T72945CAS: 2092925-89-6 | 97.55% | 279.00 €~1,882.00 € | Tue 10 Jun 25 |

Ref: 54-BUP01207
25mg | 1,955.00 € | ||
50mg | 2,547.00 € | ||
200mg | 4,220.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025

Palazestrant
CAS:2092925-89-6
Palazestrant, an antiestrogen and antineoplastic agent, effectively targets ER+/HER2+ cancer when used in conjunction with …
Formula:
C28H36FN3O
Purity:
97.55%
Color and Shape:
Liquid
Molecular weight:
449.6
Ref: TM-T72945
1mg | 279.00 € | ||
5mg | 685.00 € | ||
10mg | 938.00 € | ||
25mg | 1,444.00 € | ||
50mg | 1,882.00 € |
Estimated delivery in United States, on Tuesday 10 Jun 2025